A patient who is intubated develops sinus bradycardia. Which medication will the nurse anticipate administering to treat this symptom?
Metoclopramide (Reglan)
Atropine sulfate (Atropine)
Benztropine (Cogentin)
Bethanechal chloride (Urecholine)
The Correct Answer is B
A. Metoclopramide (Reglan): Metoclopramide is an antiemetic and prokinetic agent used to treat nausea and gastroparesis. It has no role in managing bradycardia and would not address the patient’s slow heart rate.
B. Atropine sulfate (Atropine): Atropine is an anticholinergic medication that blocks vagal stimulation of the heart, increasing heart rate. It is the drug of choice for symptomatic sinus bradycardia, especially in acute care settings, to restore adequate cardiac output.
C. Benztropine (Cogentin): Benztropine is used primarily for Parkinson’s disease and extrapyramidal symptoms. It does not have a clinically significant effect on heart rate and is not indicated for bradycardia management.
D. Bethanechol chloride (Urecholine): Bethanechol is a cholinergic agonist that stimulates bladder and gastrointestinal smooth muscle. It can actually lower heart rate rather than increase it, making it inappropriate for treating bradycardia.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. Hypernatremia: Hydrochlorothiazide promotes sodium excretion, so high sodium levels are unlikely. The medication tends to lower sodium, making hypernatremia an uncommon concern in this combination therapy.
B. Hypokalemia: Hydrochlorothiazide increases renal potassium excretion, which can lower serum potassium levels. Low potassium enhances the risk of digoxin toxicity, including arrhythmias, making close monitoring essential. This electrolyte imbalance is the most significant concern with this drug combination.
C. Hypocalcemia: Thiazide diuretics like hydrochlorothiazide actually decrease calcium excretion, so low calcium levels are not expected. Monitoring calcium is not a primary concern for this patient.
D. Hypermagnesemia: Hydrochlorothiazide increases magnesium excretion, but high magnesium levels are unlikely. Hypermagnesemia is not a common side effect of this therapy and is not a priority for monitoring in this scenario.
Correct Answer is B
Explanation
A. Complete Blood Count: A CBC evaluates red and white blood cells and platelets, which are not direct indicators of kidney function. While anemia can develop in chronic kidney disease, CBC changes are secondary and do not provide immediate information about renal clearance.
B. Creatinine: Serum creatinine is a primary marker of kidney function because it reflects the kidneys’ ability to filter waste products. Elevated levels indicate impaired glomerular filtration rate (GFR) and help guide medication dosing and fluid management in older adults.
C. Serum Sodium and Potassium: Electrolytes can be affected by kidney impairment, but changes often occur after kidney function declines significantly. While important to monitor for complications such as hyperkalemia or hyponatremia, these values are not as sensitive as creatinine for detecting early decreases in renal function.
D. Serum Albumin: Albumin measures protein status and nutritional health rather than kidney filtration ability. Low levels may be seen in nephrotic syndrome but are not a reliable indicator of general kidney function.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
